These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. In vitro steroidogenic effects of neuropeptide Y (NPY1-36), Y1 and Y2 receptor agonists (Leu31-Pro34 NPY, NPY18-36) and peptide YY (PYY) on rat adrenal capsule/zona glomerulosa. Bernet F; Maubert E; Bernard J; Montel V; Dupouy JP Regul Pept; 1994 Aug; 52(3):187-93. PubMed ID: 7800851 [TBL] [Abstract][Full Text] [Related]
26. The C-terminal flanking peptide of neuropeptide Y (NPY) is not essential for seizure-suppressant actions of prepro-NPY overexpression in male rats. Soud K; Jørgensen SH; Woldbye DPD; Sørensen AT J Neurosci Res; 2019 Mar; 97(3):362-372. PubMed ID: 30367522 [TBL] [Abstract][Full Text] [Related]
27. Modulation of intracellular calcium changes and glutamate release by neuropeptide Y1 and Y2 receptors in the rat hippocampus: differential effects in CA1, CA3 and dentate gyrus. Silva AP; Carvalho AP; Carvalho CM; Malva JO J Neurochem; 2001 Oct; 79(2):286-96. PubMed ID: 11677256 [TBL] [Abstract][Full Text] [Related]
28. Neuropeptide Y as a presynaptic modulator of norepinephrine release from the sympathetic nerve fibers in the pig pineal gland. Ziółkowska N; Lewczuk B; Przybylska-Gornowicz B Pol J Vet Sci; 2015; 18(1):53-61. PubMed ID: 25928910 [TBL] [Abstract][Full Text] [Related]
29. Ultrastructural localization of neuropeptide Y Y1 receptors in the rat medial nucleus tractus solitarius: relationships with neuropeptide Y or catecholamine neurons. Glass MJ; Chan J; Pickel VM J Neurosci Res; 2002 Mar; 67(6):753-65. PubMed ID: 11891789 [TBL] [Abstract][Full Text] [Related]
31. Disappearance rate of catecholamines, total metanephrines, and neuropeptide Y from the plasma of patients after resection of pheochromocytoma. Grouzmann E; Fathi M; Gillet M; de Torrenté A; Cavadas C; Brunner H; Buclin T Clin Chem; 2001 Jun; 47(6):1075-82. PubMed ID: 11375294 [TBL] [Abstract][Full Text] [Related]
32. Neuropeptide Y receptor subtypes, Y1 and Y2. Wahlestedt C; Grundemar L; Håkanson R; Heilig M; Shen GH; Zukowska-Grojec Z; Reis DJ Ann N Y Acad Sci; 1990; 611():7-26. PubMed ID: 2174225 [TBL] [Abstract][Full Text] [Related]
34. Plasma catecholamines and heart rate at the beginning of muscular exercise in man. Orizio C; Perini R; Comandè A; Castellano M; Beschi M; Veicsteinas A Eur J Appl Physiol Occup Physiol; 1988; 57(5):644-51. PubMed ID: 3396585 [TBL] [Abstract][Full Text] [Related]
35. Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors. Schwertfeger E; Klein T; Vonend O; Oberhauser V; Stegbauer J; Rump LC Naunyn Schmiedebergs Arch Pharmacol; 2004 May; 369(5):455-61. PubMed ID: 15103451 [TBL] [Abstract][Full Text] [Related]
36. NPY Y2 receptors in the central amygdala reduce cued but not contextual fear. Verma D; Wood J; Lach G; Mietzsch M; Weger S; Heilbronn R; Herzog H; Bonaventure P; Sperk G; Tasan RO Neuropharmacology; 2015 Dec; 99():665-74. PubMed ID: 26314208 [TBL] [Abstract][Full Text] [Related]
37. Blunted cardiac responses to exercise-induced sympathetic stimulation in non-failing aortic regurgitation: insight into role of cardiac dilation in hyporesponse of failing hearts. Matsuyama T; Sato H; Kitabatake A; Ozaki H; Imai K; Ishida Y; Hori M; Inoue M; Kamada T Jpn Circ J; 1992 Feb; 56(2):117-27. PubMed ID: 1548833 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226. Lundberg JM; Modin A Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732 [TBL] [Abstract][Full Text] [Related]